Wnt/ß-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma.

Chehrazi-Raffle, Alexander; Dorff, Tanya B; Pal, Sumanta K; Lyou, Yung

Chehrazi-Raffle, Alexander; Dorff, Tanya B; Pal, Sumanta K; Lyou, Yung.

Afiliação

Chehrazi-Raffle A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Dorff TB; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Pal SK; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Lyou Y; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

Cancers (Basel) ; 13(4)2021 Feb 20.

Article em En | MEDLINE | ID: mdl-33672668

Palavras-chave

Wnt; immune checkpoint inhibitor; immunotherapy resistance; urothelial cancer; ß-catenin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google